Domestic Pharmaceutical

GSK to offload HUL stake worth Rs 26,000 cr in largest secondary sale

Over 133 million shares, or 5.7% of the paid-up capital, are being offered for Rs 1,850-1,950 to investors through a special block window

Strong domestic and export growth to drive Ipca Laboratories' earnings

Ipca's first half performance holds testimony to its robust growth with India business growing in mid-teens

Indian pharma industry records 9.4% growth in 2018, dispels GST gloom

The industry performed better in 2018, in comparison, on a GST-impacted low base

Pharma regulator NPPA warns industry of stricter price action

Within the sector, there has been a buzz that the draft policy has been put in the cold storage because of opposition from industry

Over-the-counter route to accelerate sales growth for domestic pharma firms

Relaunching older prescription drugs in the OTC space allows companies to overcome sluggish prescription growth and also extend life of mature brands